Spire Wealth Management Tenaya Therapeutics, Inc. Transaction History
Spire Wealth Management
- $2.7 Billion
- Q2 2025
A detailed history of Spire Wealth Management transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 2,200 shares of TNYA stock, worth $4,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,200
Previous 2,200
-0.0%
Holding current value
$4,268
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TNYA
# of Institutions
95Shares Held
37MCall Options Held
91.4KPut Options Held
50.3K-
Column Group LLC San Francisco, CA9.4MShares$18.2 Million8.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.76MShares$9.23 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$7.9 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$4.38 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.84MShares$3.58 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $80.2M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...